GC Cell Corporation (KOSDAQ:144510)
16,300
-200 (-1.21%)
Jun 10, 2026, 3:30 PM KST
GC Cell Market Cap
GC Cell has a market cap or net worth of 247.95 billion as of June 10, 2026. Its market cap has decreased by -19.32% in one year.
Market Cap
247.95B
Enterprise Value
348.59B
Revenue
163.35B
Ranking
n/a
PE Ratio
n/a
Stock Price
16,300.00
Market Cap Chart
Since June 23, 2016, GC Cell's market cap has decreased from 507.65B to 247.95B, a decrease of -51.16%. That is a compound annual growth rate of -6.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 10, 2026 | 244.94B | -34.41% |
| Dec 30, 2025 | 373.42B | 4.85% |
| Dec 30, 2024 | 356.14B | -47.90% |
| Dec 28, 2023 | 683.53B | -3.46% |
| Dec 29, 2022 | 708.04B | -55.94% |
| Dec 30, 2021 | 1.61T | 65.31% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Jun 23, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Proteina | 384.58B |
| SillaJen | 350.54B |
| Genomictree | 289.09B |
| BINEX | 257.97B |
| Anterogen.Co.,Ltd. | 252.65B |
| NeoImmuneTech | 247.66B |
| HLB Therapeutics | 233.26B |
| EASY BIO,Inc. | 217.68B |